These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 30077809

  • 1. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort® (budesonide/formoterol) pressurized metered dose inhaler.
    Gillen M, Forte P, Svensson JO, Lamarca R, Burke J, Rask K, Larsdotter Nilsson U, Eckerwall G.
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [Abstract] [Full Text] [Related]

  • 2. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
    Dorinsky P, DePetrillo P, DeAngelis K, Trivedi R, Darken P, Gillen M.
    Clin Ther; 2020 Apr; 42(4):634-648. PubMed ID: 32253054
    [Abstract] [Full Text] [Related]

  • 3. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
    Ferguson GT, Tashkin DP, Skärby T, Jorup C, Sandin K, Greenwood M, Pemberton K, Trudo F.
    Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
    [Abstract] [Full Text] [Related]

  • 4. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
    Shah S, White M, Uryniak T, O'Brien CD.
    Allergy Asthma Proc; 2010 Nov; 31(1):40-8. PubMed ID: 20167144
    [Abstract] [Full Text] [Related]

  • 5. Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.
    Singh D, Collarini S, Poli G, Acerbi D, Amadasi A, Rusca A.
    Br J Clin Pharmacol; 2011 Dec; 72(6):932-9. PubMed ID: 21615456
    [Abstract] [Full Text] [Related]

  • 6. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S, Sairanen U, Haikarainen J, Korhonen J, Vahteristo M, Fuhr R, Kirjavainen M.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
    Darken P, DePetrillo P, Reisner C, St Rose E, Dorinsky P.
    Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.
    Tronde A, Gillen M, Borgström L, Lötvall J, Ankerst J.
    J Clin Pharmacol; 2008 Nov; 48(11):1300-8. PubMed ID: 18974284
    [Abstract] [Full Text] [Related]

  • 9. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ, Senn S, Mezzanotte WS.
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers.
    Dissanayake S, Mundin G, Woodward J, Lomax M, Dalvi P.
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):65-75. PubMed ID: 36796001
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
    Dunn LJ, Kerwin EM, DeAngelis K, Darken P, Gillen M, Dorinsky P.
    Pulm Pharmacol Ther; 2020 Feb; 60():101873. PubMed ID: 31841699
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.
    Kerwin EM, Siler TM, Arora S, Darken P, Rose E, Reisner C.
    Int J Chron Obstruct Pulmon Dis; 2018 Feb; 13():1483-1494. PubMed ID: 29773947
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
    Rony F, Cortellini M, Guasconi A, Mathews KS, Piccinno A, Poli G, Vanhoutte F, Klein J.
    Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
    [Abstract] [Full Text] [Related]

  • 14. Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology.
    Taylor G, Warren S, Dwivedi S, Sommerville M, Mello L, Orevillo C, Maes A, Martin UJ, Usmani OS.
    Eur J Pharm Sci; 2018 Jan 01; 111():450-457. PubMed ID: 29055732
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler.
    Chambers FE, Brown S, Ludzik AJ.
    Allergy Asthma Proc; 2009 Jan 01; 30(4):424-32. PubMed ID: 19772764
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T, Hubbell J, Xuan F, Cutler DL, Meehan AG, Kantesaria B, Wittmer BA.
    Int J Chron Obstruct Pulmon Dis; 2013 Jan 01; 8():107-16. PubMed ID: 23525511
    [Abstract] [Full Text] [Related]

  • 17. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
    Mehta R, Montembault M, Warren F, Gupta A, Brealey N, Moore A.
    J Aerosol Med Pulm Drug Deliv; 2016 Aug 01; 29(4):386-92. PubMed ID: 26824933
    [Abstract] [Full Text] [Related]

  • 18. Randomized study of the effects of Aerochamber Plus® Flow-Vu® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Fakih F, Spangenthal S, Sigal B, Darken P, Maes A, Siddiqui S, Gillen M, Reisner C, Martin UJ.
    Respir Med; 2018 May 01; 138():74-80. PubMed ID: 29724397
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 May 01; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 20. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 01; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.